Novartis CEO eyes growth strategies for Alcon

Novartis ($NVS) CEO Joe Jimenez (photo) told Reuters in an interview about his plans for the company's new eye-care division Alcon, which include broader use of implanted lenses and a larger presence in emerging markets. Report